Key terms
About GSK
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest GSK news
Yesterday
11:11am ET
Pfizer (NYSE:PFE) to Offload Haleon (NYSE:HLN) Shares Worth $2.5B
Yesterday
10:27am ET
GSK’s Jemperli Shows Promise in Endometrial Cancer Trial
Yesterday
8:35am ET
5 Stocks that Analysts Love in March 2024
Mar 13
11:00am ET
European Stocks: Unnoticed Records, Overlooked Opportunities
Mar 07
6:08am ET
GSK announces positive results from DREAMM-8 phase 3 trial for Blenrep
Mar 06
12:11pm ET
ViiV Healthcare announces interim data of LATITUDE phase III trial
Mar 06
11:10am ET
ViiV Healthcare says interim data show superior efficacy of long-acting Cabenuva
Mar 04
2:50pm ET
GSK price target raised to 1,830 GBp from 1,730 GBp at Morgan Stanley
Mar 04
1:44pm ET
GSK says study shows cabotegravir can be dosed at four months
Mar 04
4:58am ET
GSK upgraded to Buy from Neutral at Guggenheim
Feb 29
6:10am ET
GSK confirms confidential settlement reached with Boyd/Steenvoord over Zantac
Feb 26
6:59am ET
GSK announces EAGLE-1 phase III trial met primary efficacy endpoint
Feb 21
6:13am ET
GSK announces LATITUDE phase III interim trial demonstrates ‘superior efficacy’
Feb 15
1:05pm ET
GSK price target raised to 1,820 GBp from 1,650 GBp at Berenberg
Feb 15
6:03am ET
GSK completes acquisition of Aiolos Bio
Feb 12
6:19am ET
GSK receives U.S. FDA Fast Track designation for bepirovirsen in CHB
Feb 08
2:51pm ET
Moderna RSV vaccine efficacy declining quicker than peers’, says TD Cowen
Feb 08
7:12am ET
Alector announces first patient dosed in PROGRESS-AD Phase 2 trial
Feb 07
7:08am ET
Alector, GSK announce FDA granted BTD to latozinemab
Feb 06
6:16am ET
GSK says application for Shingrix accepted for review in China
Feb 06
6:12am ET
GSK says application accepted under FDA Priority Review for RSV vaccine
Feb 05
5:22pm ET
GSK presents phase 3 trial data for Blenrep in r/r multiple myeloma.
Feb 05
12:47pm ET
GSK price target raised to 1,950 GBp from 1,850 GBp at Deutsche Bank
Feb 01
3:21pm ET
GSK price target raised to 1,530 GBp from 1,450 GBp at JPMorgan
Feb 01
6:18am ET
GSK confirms confidential Zantac settlement reached with David Browne
Jan 31
7:05am ET
Options Volatility and Implied Earnings Moves Today, January 31, 2024
Jan 31
6:22am ET
GSK shares 2021-26 and 2031 outlooks
Jan 31
6:21am ET
GSK sees FY24 adjusted EPS up 6%-9%
Jan 31
6:20am ET
GSK reports Q4 adjusted EPS 28.9p, consensus 29.9p
Jan 25
9:25am ET
Guggenheim ups CymaBay price target to $28, sees M&A potential
Jan 25
5:38am ET
M & A News: Suave Brands Acquires Haleon’s (NYSE:HLN) ChapStick in $510M Deal
No recent news articles are available for GSK
No recent press releases are available for GSK
GSK Financials
Key terms
Ad Feedback
GSK Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
GSK Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range